litlas
Log inCreate account

Peter Falkai

Active 1986–2025

307
Papers
35,111
Citations
105
h-index
289
i10-index

Citations

Citations per year for Peter Falkai1987: 4 citations1988: 3 citations1989: 10 citations1990: 23 citations1991: 36 citations1992: 34 citations1993: 36 citations1994: 27 citations1995: 44 citations1996: 44 citations1997: 58 citations1998: 43 citations1999: 62 citations2000: 78 citations2001: 100 citations2002: 99 citations2003: 101 citations2004: 120 citations2005: 153 citations2006: 167 citations2007: 192 citations2008: 212 citations2009: 173 citations2010: 207 citations2011: 232 citations2012: 228 citations2013: 258 citations2014: 289 citations2015: 305 citations2016: 287 citations2017: 310 citations2018: 310 citations2019: 1,071 citations2020: 1,122 citations2021: 1,233 citations2022: 983 citations2023: 702 citations2024: 1,284 citations2025: 587 citations2026: 31 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,528 citing papers, 20.2% of this breakdownGermany: 1,716 citing papers, 9.8% of this breakdownUnited Kingdom: 1,601 citing papers, 9.2% of this breakdownChina: 985 citing papers, 5.7% of this breakdownCanada: 913 citing papers, 5.2% of this breakdownItaly: 822 citing papers, 4.7% of this breakdownAustralia: 809 citing papers, 4.6% of this breakdownNetherlands: 548 citing papers, 3.1% of this breakdownSwitzerland: 521 citing papers, 3% of this breakdownSpain: 517 citing papers, 3% of this breakdownFrance: 441 citing papers, 2.5% of this breakdownJapan: 394 citing papers, 2.3% of this breakdown
0%20.2%Other 26.7%

Institutions

Fields

  • Medicine37.7%
  • Neuroscience35.4%
  • Biochemistry, Genetics and Molecular Biology11.1%
  • Psychology10.1%
  • Computer Science1.5%
  • Health Professions0.7%
  • Other3.5%

Topics

  • Schizophrenia research and treatment7.9%
  • Functional Brain Connectivity Studies6%
  • Tryptophan and brain disorders4.3%
  • Bipolar Disorder and Treatment2.8%
  • Advanced Neuroimaging Techniques and Applications2.5%
  • Neuroscience and Neuropharmacology Research2.1%
  • Other74.4%

Coauthors

All papers

Open in search
  1. Machine Learning Approaches for Clinical Psychology and Psychiatry

    Authors: Dominic Dwyer, Peter Falkai, Nikolaos Koutsouleris - Annual Review of Clinical Psychology 2018 cited by 949

  2. Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology

    Authors: Oliver Howes, Robert A. McCutcheon, Ofer Agid, Andrea de Bartolomeis, Nico J.M. van Beveren, Michael L. Birnbaum, Michael Bloomfield, Rodrigo A. Bressan, Robert W. Buchanan, William T. Carpenter, David Castle, Leslie Citrome, Zafiris J. Daskalakis, Michael Davidson, Richard Drake, Serdar Dursun, Bjørn H. Ebdrup, Hélio Elkis, Peter Falkai, W. Wolfgang Fleischacker, Ary Gadelha, Fiona Gaughran, Birte Glenthøj, Ariel Graff‐Guerrero, Jorge Hallak, William G. Honer, James L. Kennedy, Bruce J. Kinon, Stephen M. Lawrie, Jimmy Lee, F. Markus Leweke, James H. MacCabe, Carolyn McNabb, Herbert Y. Meltzer, Hans‐Jürgen Möller, Shinchiro Nakajima, Christos Pantelis, Tiago Reis Marques, Gary Remington, Susan L. Rossell, Bruce R. Russell, Cynthia Siu, Takefumi Suzuki, Iris E. Sommer, David Taylor, Neil Thomas, Alp Üçok, Daniel Umbricht, James Walters, John M. Kane, Christoph U. Correll - American Journal of Psychiatry 2016 cited by 1,106

  3. Multimodal Machine Learning Workflows for Prediction of Psychosis in Patients With Clinical High-Risk Syndromes and Recent-Onset Depression

    Authors: Nikolaos Koutsouleris, Dominic Dwyer, Franziska Degenhardt, Carlo Maj, Maria Fernanda Urquijo-Castro, Rachele Sanfelici, David Popovic, Oemer Faruk Oeztuerk, Shalaila S. Haas, Johanna Weiske, Anne Ruef, Lana Kambeitz‐Ilankovic, Linda A. Antonucci, Susanne Neufang, Christian Schmidt-Kraepelin, Stephan Ruhrmann, Nora Penzel, Joseph Kambeitz, Theresa Haidl, Marlene Rosen, Katharine Chisholm, Anita Riecher‐Rössler, Laura Egloff, André Schmidt, Christina Andreou, Jarmo Hietala, Timo Schirmer, Georg Romer, Petra Walger, Maurizia Franscini, Nina Traber‐Walker, Benno G. Schimmelmann, Rahel Flückiger, Chantal Michel, Wulf Rössler, Oleg Borisov, Peter Krawitz, Karsten Heekeren, Roman Buechler, Christos Pantelis, Peter Falkai, Raimo K. R. Salokangas, Rebekka Lencer, Alessandro Bertolino, Stefan Borgwardt, Markus M. Nöethen, Paolo Brambilla, Stephen J. Wood, Rachel Upthegrove, Frauke Schultze‐Lutter, Anastasia Theodoridou, Eva Meisenzahl - JAMA Psychiatry 2020 cited by 263

  4. EPA guidance on physical activity as a treatment for severe mental illness: a meta-review of the evidence and Position Statement from the European Psychiatric Association (EPA), supported by the International Organization of Physical Therapists in Mental Health (IOPTMH)

    Authors: Brendon Stubbs, Davy Vancampfort, Mats Hallgren, Joseph Firth, Nicola Veronese, Marco Solmi, Serge Brand, Joachim Cordes, Berend Malchow, Markus Gerber, Andrea Schmitt, Christoph U. Correll, Marc D. Binder, Fiona Gaughran, Frank Schneider, Florence‐Emilie Kinnafick, Peter Falkai, Hans‐Jürgen Möller, Kai G. Kahl - European Psychiatry 2018 cited by 664

  5. Accelerated Brain Aging in Schizophrenia and Beyond: A Neuroanatomical Marker of Psychiatric Disorders

    Authors: Nikolaos Koutsouleris, Christos Davatzikos, Stefan Borgwardt, Christian Gaser, Ronald Bottlender, Thomas Frodl, Peter Falkai, Anita Riecher‐Rössler, H.‐J. Möller, Maximilian F. Reiser, Christos Pantelis, EM Meisenzahl - Schizophrenia Bulletin 2013 cited by 485

  6. EPA guidance on treatment of negative symptoms in schizophrenia

    Authors: Silvana Galderisi, Stefan Kaiser, István Bitter, Merete Nordentoft, Armida Mucci, Michel Sabé, Giulia Maria Giordano, M. Ø. Nielsen, Louise Birkedal Glenthøj, Pasquale Pezzella, Peter Falkai, Sonia Dollfus, Wolfgang Gäebel - European Psychiatry 2021 cited by 180

  7. Prediction Models of Functional Outcomes for Individuals in the Clinical High-Risk State for Psychosis or With Recent-Onset Depression

    Authors: Nikolaos Koutsouleris, Lana Kambeitz‐Ilankovic, Stephan Ruhrmann, Marlene Rosen, Anne Ruef, Dominic Dwyer, Marco Paolini, Katharine Chisholm, Joseph Kambeitz, Theresa Haidl, André Schmidt, J. F. E. Gillam, Frauke Schultze‐Lutter, Peter Falkai, Maximilian F. Reiser, Anita Riecher‐Rössler, Rachel Upthegrove, Jarmo Hietala, Raimo K. R. Salokangas, Christos Pantelis, Eva Meisenzahl, Stephen J. Wood, D. Bequé, Paolo Brambilla, Stefan Borgwardt - JAMA Psychiatry 2018 cited by 333

  8. Efficacy and safety of clozapine in psychotic disorders—a systematic quantitative meta-review

    Authors: Elias Wagner, Spyridon Siafis, Piyumi Fernando, Peter Falkai, William G. Honer, Astrid Röh, Dan Siskind, Stefan Leucht, Alkomiet Hasan - Translational Psychiatry 2021 cited by 169

  9. Transcranial direct current stimulation as an additional treatment to selective serotonin reuptake inhibitors in adults with major depressive disorder in Germany (DepressionDC): a triple-blind, randomised, sham-controlled, multicentre trial

    Authors: Gerrit Burkhardt, Ulrike Kumpf, Alexander Crispin, Stephan Goerigk, Elisabeth André, Christian Plewnia, Bettina Brendel, Andreas J. Fallgatter, Berthold Langguth, Mohamed A. Abdelnaim, Tobias Hebel, Claus Normann, Lukas Frase, Peter Zwanzger, Julia Diemer, Thomas Kammer, Carlos Schönfeldt‐Lecuona, Daniel Kamp, Malek Bajbouj, Nora Behler, Anja Wilkening, Tabea Nenov-Matt, Esther Dechantsreiter, Daniel Keeser, Lucia Bulubas, Ulrich Palm, Christiane Blankenstein, Ulrich Mansmann, Peter Falkai, André R. Brunoni, Alkomiet Hasan, Frank Padberg - The Lancet 2023 cited by 92

  10. EPA guidance on assessment of negative symptoms in schizophrenia

    Authors: Silvana Galderisi, Armida Mucci, Sonia Dollfus, Merete Nordentoft, Peter Falkai, Stefan Kaiser, Giulia Maria Giordano, Anaïs Vandevelde, Mette Ødegaard Nielsen, Louise Birkedal Glenthøj, Michel Sabé, Pasquale Pezzella, István Bitter, Wolfgang Gäebel - European Psychiatry 2021 cited by 232

  11. The identification, assessment and management of difficult-to-treat depression: An international consensus statement

    Authors: R. Hamish McAllister‐Williams, Celso Arango, Pierre Blier, Koen Demyttenaere, Peter Falkai, Philip Gorwood, Malcolm Hopwood, Afzal Javed, Siegfried Kasper, Gin S. Malhi, Jair C. Soares, Eduard Vieta, Allan H. Young, Ανδρέας Παπαδόπουλος, A. John Rush - Journal of Affective Disorders 2020 cited by 272

  12. Innate Immune Cells and C-Reactive Protein in Acute First-Episode Psychosis and Schizophrenia: Relationship to Psychopathology and Treatment

    Authors: Jo hann Steiner, Thomas Frodl, Kolja Schiltz, Henrik Dobrowolny, Roland Jacobs, Brisa S. Fernandes, Paul C. Guest, Gabriela Meyer-Lotz, Katrin Borucki, Sabine Bahn, Bernhard Bogerts, Peter Falkai, Hans‐Gert Bernstein - Schizophrenia Bulletin 2019 cited by 123

  13. World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance

    Authors: Alkomiet Hasan, Peter Falkai, Thomas Wobrock, Jeffrey A. Lieberman, Birte Glenthøj, Wagner F. Gattaz, Florence Thibaut, Hans‐Jürgen Möller, the Wfsbp Task Force on Treatment Guidelines for Schizophrenia - The World Journal of Biological Psychiatry 2012 cited by 636

  14. A factor analytic comparison of three commonly used depression scales (HAMD, MADRS, BDI) in a large sample of depressed inpatients

    Authors: Florian Seemüller, Rebecca Schennach, Richard Musil, Michael Obermeier, Mazda Adli, Michael Bauer, Peter Brieger, Gerd Laux, Wolfgang Gäebel, Peter Falkai, Michael Riedel, Hans‐Jürgen Möller - BMC Psychiatry 2023 cited by 60

  15. Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study

    Authors: Liping Hou, Urs Heilbronner, Franziska Degenhardt, Mazda Adli, Kazufumi Akiyama, Nirmala Akula, Raffaella Ardau, Bárbara Arias, Lena Backlund, Cláudio E. M. Banzato, Antoni Benabarre, Susanne Bengesser, Abesh Kumar Bhattacharjee, Joanna M. Biernacka, Armin Birner, Clara Brichant‐Petitjean, Elise T. Bui, Pablo Cervantes, Guo‐Bo Chen, Hsi‐Chung Chen, Caterina Chillotti, Sven Cichon, Scott R. Clark, Francesc Colom, David A. Cousins, Cristiana Cruceanu, Piotr M. Czerski, Clarissa de Rosalmeida Dantas, Alexandre Dayer, Bruno Étain, Peter Falkai, Andreas J. Forstner, Louise Frisén, Janice M. Fullerton, Sébastien Gard, Julie Garnham, Fernando S. Goes, Paul Grof, Oliver Gruber, Ryota Hashimoto, Joanna Hauser, Stefan Herms, Per Hoffmann, Andrea Hofmann, Stéphane Jamain, Esther Jiménez, Jean‐Pierre Kahn, Layla Kassem, Sarah Kittel‐Schneider, Sebastian Kliwicki, Barbara König, Ichiro Kusumi, Nina Lackner, Gonzalo Laje, Mikael Landén, Catharina Lavebratt, Marion Leboyer, Susan G. Leckband, Carlos López‐Jaramillo, Glenda MacQueen, Mirko Manchia, Lina Martinsson, Manuel Mattheisen, Michael J. McCarthy, Susan L. McElroy, Marina Mitjans, Francis M. Mondimore, Palmiero Monteleone, Caroline M. Nievergelt, Markus M. Nöthen, Urban Ösby, Norio Ozaki, Roy H. Perlis, Andrea Pfennig, Daniela Reich‐Erkelenz, Guy A. Rouleau, Peter R. Schofield, Klaus Oliver Schubert, Barbara Schweizer, Florian Seemüller, Giovanni Severino, Tatyana Shekhtman, Paul D. Shilling, Kazutaka Shimoda, Christian Simhandl, Claire Slaney, Jordan W. Smoller, Alessio Squassina, Thomas Stamm, Pavla Stopková, Sarah K. Tighe, Alfonso Tortorella, Gustavo Turecki, Julia Volkert, Stephanie H. Witt, A. Jordan Wright, L. Trevor Young, Peter P. Zandi, James B. Potash, J. Raymond DePaulo and 23 more - The Lancet 2016 cited by 400

  16. Variability and magnitude of brain glutamate levels in schizophrenia: a meta and mega-analysis

    Authors: Kate Merritt, Robert A. McCutcheon, André Alemán, Sarah A. Ashley, Katherine Beck, Wolfgang Block, Oswald Bloemen, Faith Borgan, Christiana Boules, Juan Bustillo, Arístides A. Capizzano, Jennifer M. Coughlin, Anthony S. David, Camilo de la Fuente‐Sandoval, Arsime Demjaha, Kara Dempster, Kim Q., Fei Du, Peter Falkai, Beata Galińska-Skok, Jürgen Gallinat, Charles Gasparovic, Cedric E. Ginestet, Naoki Gotō, Ariel Graff‐Guerrero, Beng‐Choon Ho, Oliver Howes, Sameer Jauhar, Peter Jeon, Tadafumi Kato, Charles A. Kaufmann, Lawrence S. Kegeles, Matcheri S. Keshavan, Sang-Young Kim, B. King, Hiroshi Kunugi, John Lauriello, Pablo León-Ortíz, Edith J. Liemburg, Meghan McIlwain, Gemma Modinos, Elias Mouchlianitis, Jun Nakamura, Igor Nenadić, Döst Öngür, Miho Ota, Lena Palaniyappan, Christos Pantelis, Tulsi Patel, Eric Plitman, Sotirios Posporelis, Scot E. Purdon, Jürgen R. Reichenbach, Perry F. Renshaw, Francisco Reyes-Madrigal, Bruce R. Russell, Akira Sawa, Martin Schaefer, Dikoma C. Shungu, Stefan Smesny, Jeffrey A. Stanley, James Stone, Agata Szulc, Reggie Taylor, Katharine N. Thakkar, Jean Théberge, Philip G. Tibbo, Thérèse van Amelsvoort, Jerzy Walecki, Peter Williamson, Stephen J. Wood, Lijing Xin, Hidenori Yamasue, Philip McGuire, Alice Egerton, the 1H-MRS in Schizophrenia Investigators, Camilo de la Fuente-Sandoval, Thérèse van Amelsvoort, Philip K. McGuire - Molecular Psychiatry 2023 cited by 75

  17. Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies

    Authors: C F M G van Kesteren, Hendrik Gremmels, Lot D. de Witte, Elly M. Hol, Arthur R. Van Gool, Peter Falkai, René S. Kahn, Iris E. Sommer - Translational Psychiatry 2017 cited by 373

  18. Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach

    Authors: Nikolaos Koutsouleris, René S. Kahn, Adam M. Chekroud, Stefan Leucht, Peter Falkai, Thomas Wobrock, Eske M. Derks, Wolfgang Fleischhacker, Alkomiet Hasan - The Lancet Psychiatry 2016 cited by 229

  19. Anti‐amyloid antibody treatments for Alzheimer's disease

    Authors: Robert Perneczky, Geert Dom, Andrew Chan, Peter Falkai, Claudio L. Bassetti - European Journal of Neurology 2023 cited by 94

  20. Associations of psychiatric disease and ageing with FKBP5 expression converge on superficial layer neurons of the neocortex

    Authors: Natalie Matosin, Janine Arloth, Darina Czamara, Katrina Z. Edmond, Malosree Maitra, Anna S. Fröhlich, Silvia Martinelli, Dominic Kaul, Rachael Bartlett, Amber R. Curry, Nils C. Gassen, Kathrin Hafner, Nikola S. Müller, Karolina Worf, Ghalia Rehawi, Corina Nagy, Thorhildur Halldorsdottir, Cristiana Cruceanu, Miriam Gagliardi, Nathalie Gerstner, Maik Ködel, Vanessa Murek, Michael J. Ziller, Elizabeth Scarr, Ran Tao, Andrew E. Jaffe, Thomas Arzberger, Peter Falkai, Joel E. Kleinmann, Daniel R. Weinberger, Naguib Mechawar, Andrea Schmitt, Brian Dean, Gustavo Turecki, Thomas M. Hyde, Elisabeth B. Binder - Acta Neuropathologica 2023 cited by 55

  21. Aberrant Functional Whole-Brain Network Architecture in Patients With Schizophrenia: A Meta-analysis

    Authors: Joseph Kambeitz, Lana Kambeitz‐Ilankovic, Carlos Cabral, Dominic Dwyer, Vince D. Calhoun, Martijn P. van den Heuvel, Peter Falkai, Nikolaos Koutsouleris, Berend Malchow - Schizophrenia Bulletin 2016 cited by 202

  22. Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report

    Authors: Mirko Manchia, Mazda Adli, Nirmala Akula, Raffaella Ardau, Jean-Michel Aubry, Lena Backlund, Cláudio E. M. Banzato, Bernhard T. Baune, Frank Bellivier, Susanne Bengesser, Joanna M. Biernacka, Clara Brichant‐Petitjean, Elise T. Bui, Cynthia Calkin, Andrew Tai Ann Cheng, Caterina Chillotti, Sven Cichon, Scott R. Clark, Piotr M. Czerski, Clarissa de Rosalmeida Dantas, Maria Del Zompo, J. Raymond DePaulo, Sevilla D. Detera‐Wadleigh, Bruno Étain, Peter Falkai, Louise Frisén, Mark A. Frye, Janice M. Fullerton, Sébastien Gard, Julie Garnham, Fernando S. Goes, Paul Grof, Oliver Gruber, Ryota Hashimoto, Joanna Hauser, Urs Heilbronner, Rebecca Hoban, Liping Hou, Stéphane Jamain, Jean‐Pierre Kahn, Layla Kassem, Tadafumi Kato, John R. Kelsoe, Sarah Kittel‐Schneider, Sebastian Kliwicki, Po‐Hsiu Kuo, Ichiro Kusumi, Gonzalo Laje, Catharina Lavebratt, Marion Leboyer, Susan G. Leckband, Carlos López‐Jaramillo, Mario Maj, Alain Malafosse, Lina Martinsson, Takuya Masui, Philip B. Mitchell, Frank Mondimore, Palmiero Monteleone, Audrey Nallet, M. Neuner, Tomáš Novák, Claire O’Donovan, Urban Ösby, Norio Ozaki, Roy H. Perlis, Andrea Pfennig, James B. Potash, Daniela Reich‐Erkelenz, Andreas Reif, Eva Z. Reininghaus, Sara Richardson, Guy A. Rouleau, Janusz Rybakowski, Martin Schalling, Peter R. Schofield, Oliver Schubert, Barbara Schweizer, Florian Seemüller, Maria Grigoroiu‐Serbânescu, Giovanni Severino, Lisa R. Seymour, Claire Slaney, Jordan W. Smoller, Alessio Squassina, Thomas Stamm, Jo Steele, Pavla Stopková, Sarah K. Tighe, Alfonso Tortorella, Gustavo Turecki, Naomi R. Wray, A. Jordan Wright, Peter P. Zandi, David Zilles‐Wegner, Michael Bauer, Marcella Rietschel, Francis J. McMahon, Thomas G. Schulze, Martin Alda - PLoS ONE 2013 cited by 424

  23. Left Prefrontal High-Frequency Repetitive Transcranial Magnetic Stimulation for the Treatment of Schizophrenia with Predominant Negative Symptoms: A Sham-Controlled, Randomized Multicenter Trial

    Authors: Thomas Wobrock, Birgit Guse, Joachim Cordes, Wolfgang Wölwer, Georg Winterer, Wolfgang Gäebel, Berthold Langguth, Michael Landgrebe, Peter Eichhammer, Elmar Frank, Göran Hajak, Christian Ohmann, Pablo Emilio Verde, Marcella Rietschel, Raees Ahmed, William G. Honer, Berend Malchow, Thomas Schneider-Axmann, Peter Falkai, Alkomiet Hasan - Biological Psychiatry 2014 cited by 169

  24. Neurodevelopmental disturbances in schizophrenia: evidence from genetic and environmental factors

    Authors: Andrea Schmitt, Peter Falkai, Sergi Papiol - Journal of Neural Transmission 2022 cited by 87